MedTrace Logo

Components of Chlorhexidine Gluconate Dressing

NCT01112020 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 45

Last updated 2025-11-26

No results posted yet for this study

Summary

The purpose of this study is to determine the contents of a chlorhexidine-containing dressing after use.

Conditions

  • Healthy

Interventions

DEVICE

CHG Catheter Dressing Patch

2% CHG dressing applied to 7 sites

DEVICE

Biopatch

Biopatch applied to 7 sites

DEVICE

Tegaderm CHG

Tegaderm CHG IV Securement Dressing applied to 7 sites

Sponsors & Collaborators

  • C. R. Bard

    lead INDUSTRY

Principal Investigators

  • Ramon Vargas, MD · Cetero Research, San Antonio

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2010-04-30
Primary Completion
2010-05-31
Completion
2010-05-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01112020 on ClinicalTrials.gov